BIOMAT Database Logo BIOMAT Database Logo

[Potassium chlorazepate administered orally in alcoholic detoxification]. 1989

J P Roussaux, and M Derely, and D Hers

30 alcoholic patients were studied during a detoxification period of 14 days in the hospital. Variable doses (maximum 300 mg) of potassium clorazepate allowed to achieve an harmless and rather comfortable detoxification, evaluated through internationally used skates (SSA and HSCL).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003009 Clorazepate Dipotassium A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. Chlorazepate,Dipotassium Chlorazepate,4306-CB,Clorazepate,Clorazepate Monopotassium,Clorazepic Acid,Tranxene,Tranxilium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents

Related Publications

J P Roussaux, and M Derely, and D Hers
THE TOXICITY OF ORALLY ADMINISTERED POTASSIUM SALTS IN RENAL INSUFFICIENCY.
March 1941, The Journal of clinical investigation,
J P Roussaux, and M Derely, and D Hers
Carcinogenicity of potassium bromate administered orally to F344 rats.
November 1983, Journal of the National Cancer Institute,
J P Roussaux, and M Derely, and D Hers
A spectral and polarographic study of potassium chlorazepate.
June 1975, Analytica chimica acta,
J P Roussaux, and M Derely, and D Hers
Neurobehavioral and Cardiovascular Effects of Potassium Cyanide Administered Orally to Mice.
September 2016, International journal of toxicology,
J P Roussaux, and M Derely, and D Hers
[Clinical experimentation with dipotassium chlorazepate (4306 CB) administered parenterally].
October 1972, La Clinica terapeutica,
J P Roussaux, and M Derely, and D Hers
Micronucleus test with potassium chromate(VI) administered intraperitoneally and orally to mice.
August 1989, Mutation research,
J P Roussaux, and M Derely, and D Hers
Effect of orally administered potassium iodate on blood sugar response to thiourea.
April 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J P Roussaux, and M Derely, and D Hers
[Cortisone administered orally].
April 1951, Journal des praticiens; revue generale de clinique et de therapeutique,
J P Roussaux, and M Derely, and D Hers
[Orally administered syntocinon].
January 1966, Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie,
J P Roussaux, and M Derely, and D Hers
[Alcoholic detoxification in primary care].
May 2005, Atencion primaria,
Copied contents to your clipboard!